Business
Exousia Pro Reports Positive Outcome in Legal Proceeding
Exousia Pro Reports Positive Outcome in Legal Proceeding.
About this update from Marijuana Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Exousia Pro Reports Positive Outcome in Legal Proceeding\r\n \r\n \r\n\r\n\r\nExousia Pro Reports Positive Outcome in Legal Proceeding\r\n\r\n\r\n\r\n\r\n\r\nFocused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on exosome-based therapies, today issued a positive update regarding its legal proceedings against Donald Steinberg, the former sole officer and director, and other related shareholders.\r\n Following a hearing held yesterday, the company is pleased to report that significant protections for shareholders have been put in place. While the motion for a Temporary Restraining Order (TRO) was not heard due to a lack of available court time, a mutually agreed-upon standstill order was executed on all shares held by the former CEO, representing approximately 10.5% of the current shares outstanding. This pivotal agreement ensures these shares will remain in their current position, providing a clear benefit to all shareholders.\r\n In a further proactive measure, Exousia Pro executed two rescission agreements. These agreements will be used to block the removal of legends on an additional 3,250,000 shares, representing approximately 8% of the current outstanding shares, if they are presented to the company's transfer agent for processing.\r\n \"We are very pleased with the outcome of the hearing, as key protections were secured for our shareholders,\" stated Matt Dwyer, President of Exousia Pro, Inc. \"Our legal strategy is focused on a surgical approach to achieve our objectives and protect our shareholders' interests. This successful step allows us to refocus our full attention on our primary mission: developing innovative exosome therapies for the cancer market.\"\r\n Exousia Pro is now fully committed to driving forward its business objectives with renewed energy and focus. The company will be releasing new and exciting updates on its ongoing studies, therapies, nutraceutical products, patents, and expansion initiatives.\r\n About Us\r\n Exousia Pro (formerly Marijuana, Inc.) is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology. The company's patented manufacturing proce...